Steven Kozlowski

Years Active: 2020-2024
Publications (10 Years): 4

US Food and Drug Administration

This page only lists publications with an associated author ORCID identifier.

Affiliation History

US Food and Drug Administration

United States

Director, Office of Biotechnology Products :: Office of Biotechnology Products/OPQ/CDER

Publications

Steven Kozlowski, Ellen Tworkoski, Sai Dharmarajan, Natasha Flowers, Andrew Kwist, Shanlai Shangguan, Yoganand Chillarige, Michael Wernecke, Tom MaCurdy, Jeffrey A Kelman, David J Graham
Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomes. Pharmacoepidemiology and drug safety 33 (2) (2024)
Steven Kozlowski, Natasha Flowers, Andrew Kwist, Sarah K Dutcher, Michael Wernecke, Jeffrey A Kelman, David J Graham
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population. Journal of general internal medicine 37 (16) (2022)
Zhao-Hua Zhou, Sai Dharmarajan, Mari Lehtimaki, Susan L Kirshner, Steven Kozlowski
Early antibody responses associated with survival in COVID19 patients. PLoS pathogens 17 (7) (2021)
Steven Kozlowski, Natasha Flowers, Noy Birger, Michael Wernecke, Thomas E MaCurdy, Jeffrey A Kelman, David J Graham
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population. Journal of general internal medicine 36 (7) (2020)

Steven Kozlowski.css-eqlu8i{font-size:small;padding-left:4px;}